Dyrskjøt L - Search Results

1

Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.

Zieger K, Dyrskjøt L, Wiuf C, Jensen JL, Andersen CL, Jensen KM, Ørntoft TF. Zieger K, et al. Among authors: dyrskjot l. Clin Cancer Res. 2005 Nov 1;11(21):7709-19. doi: 10.1158/1078-0432.CCR-05-1130. Clin Cancer Res. 2005. PMID: 16278391

2

Identifying distinct classes of bladder carcinoma using microarrays.

Dyrskjøt L, Thykjaer T, Kruhøffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S, Wolf H, Orntoft TF. Dyrskjøt L, et al. Nat Genet. 2003 Jan;33(1):90-6. doi: 10.1038/ng1061. Epub 2002 Dec 9. Nat Genet. 2003. PMID: 12469123

3

Technical evaluation of cDNA microarrays.

Frederiksen CM, Aaboe M, Dyrskjøt L, Laurberg S, Wolf H, Ørntoft TF, Kruhøffer M. Frederiksen CM, et al. Among authors: dyrskjot l. APMIS Suppl. 2003;(109):96-101. APMIS Suppl. 2003. PMID: 12874958

4

Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics.

Dyrskjøt L. Dyrskjøt L. Expert Rev Mol Diagn. 2003 Sep;3(5):635-47. doi: 10.1586/14737159.3.5.635. Expert Rev Mol Diagn. 2003. PMID: 14510183 Review.

5

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

Dyrskjøt L, Kruhøffer M, Thykjaer T, Marcussen N, Jensen JL, Møller K, Ørntoft TF. Dyrskjøt L, et al. Cancer Res. 2004 Jun 1;64(11):4040-8. doi: 10.1158/0008-5472.CAN-03-3620. Cancer Res. 2004. PMID: 15173019

6

A molecular signature in superficial bladder carcinoma predicts clinical outcome.

Dyrskjøt L, Zieger K, Kruhøffer M, Thykjaer T, Jensen JL, Primdahl H, Aziz N, Marcussen N, Møller K, Orntoft TF. Dyrskjøt L, et al. Clin Cancer Res. 2005 Jun 1;11(11):4029-36. doi: 10.1158/1078-0432.CCR-04-2095. Clin Cancer Res. 2005. PMID: 15930337

7

Gene expression signatures for colorectal cancer microsatellite status and HNPCC.

Kruhøffer M, Jensen JL, Laiho P, Dyrskjøt L, Salovaara R, Arango D, Birkenkamp-Demtroder K, Sørensen FB, Christensen LL, Buhl L, Mecklin JP, Järvinen H, Thykjaer T, Wikman FP, Bech-Knudsen F, Juhola M, Nupponen NN, Laurberg S, Andersen CL, Aaltonen LA, Ørntoft TF. Kruhøffer M, et al. Among authors: dyrskjot l. Br J Cancer. 2005 Jun 20;92(12):2240-8. doi: 10.1038/sj.bjc.6602621. Br J Cancer. 2005. PMID: 15956967 Free PMC article.

8

Gene expression profiling of noninvasive primary urothelial tumours using microarrays.

Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrskjøt L, Orntoft TF. Aaboe M, et al. Among authors: dyrskjot l. Br J Cancer. 2005 Nov 14;93(10):1182-90. doi: 10.1038/sj.bjc.6602813. Br J Cancer. 2005. PMID: 16265353 Free PMC article.

9

SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization.

Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sørensen FB, Thykjaer T, Sauter G, Jensen KM, Dyrskjøt L, Ørntoft T. Aaboe M, et al. Among authors: dyrskjot l. Cancer Res. 2006 Apr 1;66(7):3434-42. doi: 10.1158/0008-5472.CAN-05-3456. Cancer Res. 2006. PMID: 16585165 Free article.

10

Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.

Ylisaukko-oja SK, Cybulski C, Lehtonen R, Kiuru M, Matyjasik J, Szymañska A, Szymañska-Pasternak J, Dyrskjot L, Butzow R, Orntoft TF, Launonen V, Lubiñski J, Aaltonen LA. Ylisaukko-oja SK, et al. Among authors: dyrskjot l. Eur J Hum Genet. 2006 Jul;14(7):880-3. doi: 10.1038/sj.ejhg.5201630. Epub 2006 Apr 26. Eur J Hum Genet. 2006. PMID: 16639410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page